Elizabeth E. Reed, SVP, GC & CORPORATE SECRETARY at Travere Therapeutics, Inc. (TVTX), sold 17,902 shares at $19.78 ($354K) on 2025-02-03, disclosed to the SEC on 2025-02-04.
Scheduled sale ($354k) by SVP, GC & CORPORATE SECRETARY under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.78 | 8,951 | $177K | 50.0% |
| 2 | $19.78 | 8,951 | $177K | 50.0% |
| Total | $19.78 avg | 17,902 | $354K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.1M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $300K | — | Filing → |
| TVTX | SELL | 2026-03-18 | $562K | — | Filing → |